Package 50242-090-02

{"route": ["ORAL"], "spl_id": "77f36fc9-7ae6-425a-9dff-79ab4476c864", "openfda": {"nui": ["N0000175605", "N0000175076", "N0000182138", "N0000185503"], "unii": ["207SMY3FQT"], "rxcui": ["1147223", "1147228"], "spl_set_id": ["38eea320-7e0c-485a-bc30-98c3c45e2763"], "pharm_class_epc": ["Kinase Inhibitor [EPC]"], "pharm_class_moa": ["Protein Kinase Inhibitors [MoA]", "Cytochrome P450 1A2 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["Genentech, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (50242-090-02)  / 112 TABLET, FILM COATED in 1 BOTTLE, PLASTIC", "package_ndc": "50242-090-02", "marketing_start_date": "20150908"}], "brand_name": "ZELBORAF", "product_id": "50242-090_77f36fc9-7ae6-425a-9dff-79ab4476c864", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 1A2 Inhibitors [MoA]", "Kinase Inhibitor [EPC]", "P-Glycoprotein Inhibitors [MoA]", "Protein Kinase Inhibitors [MoA]"], "product_ndc": "50242-090", "generic_name": "Vemurafenib", "labeler_name": "Genentech, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ZELBORAF", "active_ingredients": [{"name": "VEMURAFENIB", "strength": "240 mg/1"}], "application_number": "NDA202429", "marketing_category": "NDA", "marketing_start_date": "20110817", "listing_expiration_date": "20261231"}